Blended Interferon-Alpha and Interleukin-2 Preparation from Canada
A mixed solution of recombinant interferon-alpha (IFN-α) and interleukin-2 (IL-2) for immunotherapy in viral infections and cancer. Falls under HTS 3002.14.00 as mixed immunological products (interferons and interleukins) not prepared for retail sale or in measured doses.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Submit lab reports confirming mixture of immunological proteins like IFN and IL-2, not simple solutions
• Ensure cold chain compliance with temperature logs; FDA prior notice required for biological imports